Artal Group
Latest statistics and disclosures from Artal Group's latest quarterly 13F-HR filing:
- Top 5 stock holdings are WW, SEER, BGNE, LXRX, XLRN, and represent 29.42% of Artal Group's stock portfolio.
- Added to shares of these 10 stocks: SEER (+$328M), BMY (+$62M), SQZ (+$47M), Z (+$45M), IGMS (+$45M), PRAX (+$41M), CCXI (+$40M), KRON (+$39M), CERE (+$38M), LXRX (+$37M).
- Started 25 new stock positions in ZYME, IQ, SLB, KDNY, MRNS, CLDX, FMTX, SGTX, IDRA, YMTX.
- Reduced shares in these 10 stocks: QQQ (-$572M), , , BNTX (-$60M), BAC (-$48M), , MRNA (-$26M), MS (-$24M), AAPL (-$23M), C (-$22M).
- Sold out of its positions in AXDX, ADPT, Aduro Biotech, AAPL, AUTL, BAC, C, CTMX, EPZM, ESPR.
- Artal Group was a net seller of stock by $-194M.
- Artal Group has $4.7B in assets under management (AUM), dropping by 13.08%.
- Central Index Key (CIK): 0001053906
Tip: Access up to 7 years of quarterly data
Positions held by Artal Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Artal Group
Companies in the Artal Group portfolio as of the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Ww Intl (WW) | 7.8 | $362M | 15M | 24.40 | ||
| Seer Com Cl A (SEER) | 7.0 | $328M | NEW | 5.8M | 56.14 | |
| Beigene Sponsored Adr (BGNE) | 5.5 | $258M | +11% | 1.0M | 258.39 | |
| Lexicon Pharmaceuticals Com New (LXRX) | 5.2 | $243M | +18% | 71M | 3.42 | |
| Acceleron Pharma (XLRN) | 3.8 | $179M | 1.4M | 127.94 | ||
| Alnylam Pharmaceuticals (ALNY) | 2.8 | $130M | +25% | 1.0M | 129.97 | |
| Fate Therapeutics (FATE) | 2.7 | $127M | -6% | 1.4M | 90.93 | |
| Mirati Therapeutics (MRTX) | 2.4 | $110M | 500k | 219.64 | ||
| Igm Biosciences (IGMS) | 2.3 | $106M | +74% | 1.2M | 88.29 | |
| Scholar Rock Hldg Corp (SRRK) | 2.2 | $102M | -15% | 2.1M | 48.53 | |
| GDS HLDGS Sponsored Ads (GDS) | 2.0 | $94M | 1.0M | 93.64 | ||
| Alibaba Group Hldg Sponsored Ads (BABA) | 2.0 | $93M | -5% | 400k | 232.73 | |
| Allovir (ALVR) | 1.9 | $89M | 2.3M | 38.44 | ||
| Argenx Se Sponsored Adr (ARGX) | 1.9 | $88M | -7% | 300k | 294.09 | |
Setup an alertArtal Group will file the next quarterly 13-HR in about 1 months. Would you like to be notified? |
||||||
| Abbvie Call Option (ABBV) | 1.8 | $86M | +60% | 800k | 107.15 | |
| Biontech Se Sponsored Ads (BNTX) | 1.8 | $82M | -42% | 1.0M | 81.52 | |
| Amicus Therapeutics (FOLD) | 1.7 | $81M | -12% | 3.5M | 23.09 | |
| Generation Bio (GBIO) | 1.7 | $80M | 2.8M | 28.35 | ||
| Tg Therapeutics (TGTX) | 1.7 | $78M | 1.5M | 52.02 | ||
| Zillow Group Cl C Cap Stk (Z) | 1.5 | $71M | +175% | 550k | 129.80 | |
| Schrodinger (SDGR) | 1.4 | $63M | -11% | 797k | 79.18 | |
| Bristol Myers Squibb Call Option (BMY) | 1.3 | $62M | NEW | 1.0M | 62.03 | |
| Ke Hldgs Sponsored Ads (BEKE) | 1.3 | $62M | +14% | 1.0M | 61.54 | |
| Morphic Hldg (MORF) | 1.2 | $55M | 1.7M | 33.55 | ||
| Atara Biotherapeutics (ATRA) | 1.2 | $55M | +24% | 2.8M | 19.63 | |
| Black Diamond Therapeutics (BDTX) | 1.1 | $53M | +8% | 1.6M | 32.05 | |
| Sqz Biotech (SQZ) | 1.0 | $47M | NEW | 1.6M | 28.98 | |
| Turning Point Therapeutics I (TPTX) | 0.9 | $43M | +7% | 350k | 121.85 | |
| Praxis Precision Medicines I (PRAX) | 0.9 | $41M | NEW | 750k | 55.02 | |
| Chemocentryx (CCXI) | 0.9 | $40M | NEW | 650k | 61.92 | |
| Kronos Bio (KRON) | 0.8 | $39M | NEW | 1.3M | 29.87 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.8 | $38M | NEW | 2.3M | 16.58 | |
| Iteos Therapeutics (ITOS) | 0.8 | $37M | 1.1M | 33.82 | ||
| Foghorn Therapeutics (FHTX) | 0.7 | $35M | NEW | 1.7M | 20.27 | |
| Sage Therapeutics (SAGE) | 0.7 | $35M | +79% | 400k | 86.51 | |
| I Mab Sponsored Ads (IMAB) | 0.7 | $34M | 725k | 47.15 | ||
| Denali Therapeutics (DNLI) | 0.7 | $34M | 400k | 83.76 | ||
| Springworks Therapeutics (SWTX) | 0.7 | $33M | +57% | 450k | 72.52 | |
| Mersana Therapeutics (MRSN) | 0.7 | $32M | +20% | 1.2M | 26.61 | |
| Trillium Therapeutics Com New (TRIL) | 0.7 | $31M | +40% | 2.1M | 14.71 | |
| Rubius Therapeutics (RUBY) | 0.6 | $29M | 3.8M | 7.59 | ||
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $29M | -16% | 500k | 57.07 | |
| Taysha Gene Therapies Com Shs (TSHA) | 0.6 | $28M | -8% | 1.0M | 26.54 | |
| Adverum Biotechnologies (ADVM) | 0.6 | $27M | +38% | 2.5M | 10.84 | |
| Replimune Group (REPL) | 0.6 | $27M | 700k | 38.15 | ||
| Albireo Pharma (ALBO) | 0.6 | $26M | -17% | 700k | 37.51 | |
| Alx Oncology Hldgs (ALXO) | 0.6 | $26M | +200% | 300k | 86.20 | |
| Uniqure Nv SHS (QURE) | 0.5 | $25M | -6% | 700k | 36.13 | |
| Novagold Res Com New (NG) | 0.5 | $25M | 2.6M | 9.67 | ||
| Gossamer Bio (GOSS) | 0.5 | $23M | 2.4M | 9.67 | ||
| Translate Bio (TBIO) | 0.5 | $22M | -14% | 1.2M | 18.43 | |
| Agenus Com New (AGEN) | 0.5 | $22M | 6.9M | 3.18 | ||
| Schlumberger Call Option (SLB) | 0.5 | $22M | NEW | 1.0M | 21.83 | |
| Bridgebio Pharma (BBIO) | 0.5 | $21M | -25% | 300k | 71.11 | |
| Kura Oncology (KURA) | 0.4 | $20M | +9% | 600k | 32.66 | |
| Repare Therapeutics Ord (RPTX) | 0.4 | $20M | 570k | 34.30 | ||
| Bio-techne Corporation (TECH) | 0.4 | $19M | 60k | 317.55 | ||
| Iovance Biotherapeutics (IOVA) | 0.4 | $19M | 400k | 46.40 | ||
| Forma Therapeutics Hldgs SHS (FMTX) | 0.4 | $18M | NEW | 500k | 34.90 | |
| Trip Com Group Ads (TCOM) | 0.4 | $17M | -12% | 500k | 33.73 | |
| Relay Therapeutics (RLAY) | 0.4 | $17M | 400k | 41.56 | ||
| Zymeworks (ZYME) | 0.4 | $17M | NEW | 350k | 47.26 | |
| Nanobiotix Sa Sponsored Ads (NBTX) | 0.4 | $17M | NEW | 1.0M | 16.50 | |
| Cardiff Oncology (CRDF) | 0.3 | $16M | 900k | 17.99 | ||
| Kymera Therapeutics (KYMR) | 0.3 | $16M | 250k | 62.00 | ||
| Stoke Therapeutics (STOK) | 0.3 | $16M | -7% | 250k | 61.93 | |
| Tcr2 Therapeutics Inc cs (TCRR) | 0.3 | $16M | 500k | 30.93 | ||
| Iqiyi Sponsored Ads (IQ) | 0.3 | $15M | NEW | 850k | 17.48 | |
| Fibrogen (FGEN) | 0.3 | $15M | +5% | 400k | 37.09 | |
| Curis Com New (CRIS) | 0.3 | $15M | +28% | 1.8M | 8.19 | |
| Bellus Health Com New (BLU) | 0.3 | $15M | +900% | 4.8M | 3.06 | |
| Krystal Biotech (KRYS) | 0.3 | $14M | 238k | 60.00 | ||
| Y Mabs Therapeutics (YMAB) | 0.3 | $14M | 285k | 49.51 | ||
| Aurinia Pharmaceuticals (AUPH) | 0.3 | $14M | 1.0M | 13.83 | ||
| Selecta Biosciences (SELB) | 0.3 | $14M | 4.5M | 3.03 | ||
| Intellia Therapeutics (NTLA) | 0.3 | $14M | +31% | 250k | 54.40 | |
| Harpoon Therapeutics (HARP) | 0.3 | $13M | 800k | 16.61 | ||
| Sigilon Therapeutics (SGTX) | 0.3 | $13M | NEW | 276k | 48.03 | |
| BioMarin Pharmaceutical Call Option (BMRN) | 0.3 | $13M | 150k | 87.69 | ||
| Olema Pharmaceuticals (OLMA) | 0.3 | $13M | NEW | 261k | 48.08 | |
| Danaher Corporation (DHR) | 0.2 | $11M | -33% | 50k | 222.14 | |
| Immunic (IMUX) | 0.2 | $11M | -12% | 700k | 15.29 | |
| Hookipa Pharma Inc equity (HOOK) | 0.2 | $11M | +58% | 950k | 11.09 | |
| Cytokinetics Com New (CYTK) | 0.2 | $10M | NEW | 500k | 20.78 | |
| Spero Therapeutics (SPRO) | 0.2 | $9.7M | -16% | 500k | 19.39 | |
| Bruker Corporation (BRKR) | 0.2 | $9.5M | 175k | 54.13 | ||
| Aptinyx (APTX) | 0.2 | $8.7M | +66% | 2.5M | 3.46 | |
| Evelo Biosciences (EVLO) | 0.2 | $8.5M | +47% | 700k | 12.09 | |
| Applied Therapeutics (APLT) | 0.2 | $8.4M | 380k | 22.01 | ||
| Aeglea Biotherapeutics (AGLE) | 0.2 | $8.2M | 1.0M | 7.87 | ||
| Syros Pharmaceuticals (SYRS) | 0.2 | $8.1M | +61% | 750k | 10.85 | |
| American Airls Call Option (AAL) | 0.2 | $7.9M | 500k | 15.77 | ||
| Alpine Immune Sciences (ALPN) | 0.2 | $7.5M | 593k | 12.60 | ||
| Aravive (ARAV) | 0.2 | $7.4M | 1.3M | 5.64 | ||
| Metacrine Ord (MTCR) | 0.2 | $7.3M | -29% | 925k | 7.86 | |
| Celldex Therapeutics Com New (CLDX) | 0.2 | $7.0M | NEW | 400k | 17.52 | |
| 111 Ads (YI) | 0.1 | $7.0M | +53% | 1.0M | 6.95 | |
| Leap Therapeutics (LPTX) | 0.1 | $6.8M | +6% | 3.0M | 2.25 | |
| Dyne Therapeutics (DYN) | 0.1 | $6.3M | -18% | 300k | 21.00 | |
| Ovid Therapeutics (OVID) | 0.1 | $5.8M | 2.5M | 2.31 | ||
| Cyclerion Therapeutics (CYCN) | 0.1 | $5.4M | 1.8M | 2.99 | ||
| Moderna (MRNA) | 0.1 | $5.2M | -83% | 50k | 104.48 | |
| Ac Immune Sa SHS (ACIU) | 0.1 | $5.2M | 1.0M | 5.17 | ||
| Contrafect Corp Com New (CFRX) | 0.1 | $5.1M | NEW | 1.0M | 5.05 | |
| Proqr Therapeutics N V Shs Euro (PRQR) | 0.1 | $5.0M | 1.2M | 4.20 | ||
| Kinnate Biopharma (KNTE) | 0.1 | $5.0M | NEW | 125k | 39.78 | |
| Seres Therapeutics (MCRB) | 0.1 | $4.9M | -33% | 200k | 24.50 | |
| Kaleido Biosciences Ord (KLDO) | 0.1 | $4.6M | 501k | 9.10 | ||
| Axcella Health Inc equity (AXLA) | 0.1 | $3.7M | 713k | 5.19 | ||
| Yumanity Therapeutics (YMTX) | 0.1 | $3.7M | NEW | 217k | 17.00 | |
| Marinus Pharmaceuticals Com New (MRNS) | 0.1 | $3.7M | NEW | 300k | 12.20 | |
| Avidity Biosciences Ord (RNA) | 0.1 | $3.6M | 143k | 25.52 | ||
| Oric Pharmaceuticals (ORIC) | 0.1 | $3.4M | -29% | 100k | 33.85 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.1 | $3.0M | 95k | 32.01 | ||
| Chinook Therapeutics (KDNY) | 0.1 | $2.9M | NEW | 181k | 15.86 | |
| Protagonist Therapeutics (PTGX) | 0.1 | $2.7M | 133k | 20.16 | ||
| Mei Pharma Com New (MEIP) | 0.0 | $2.0M | 760k | 2.64 | ||
| Select Sector Spdr Tr Energy Call Option (XLE) | 0.0 | $1.9M | 50k | 37.90 | ||
| Idera Pharmaceuticals Com Par (IDRA) | 0.0 | $1.8M | NEW | 500k | 3.67 | |
| Adicet Bio (ACET) | 0.0 | $1.8M | 129k | 14.05 | ||
| Chiasma (CHMA) | 0.0 | $1.7M | 380k | 4.35 | ||
| Orchard Therapeutics Ads (ORTX) | 0.0 | $1.5M | 352k | 4.32 | ||
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.0 | $1.3M | 111k | 11.38 | ||
| Rigel Pharmaceuticals Com New (RIGL) | 0.0 | $1.1M | 321k | 3.50 | ||
| Surface Oncology (SURF) | 0.0 | $924k | NEW | 100k | 9.24 | |
| Cerevel Therapeutics Hldng I *w Exp 06/09/202 (CEREW) | 0.0 | $450k | NEW | 80k | 5.65 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 0.0 | $449k | 225k | 2.00 | ||
Past Filings by Artal Group
SEC 13F filings are viewable for Artal Group going back to 2012
- Artal Group 2020 Q4 filed Feb. 11, 2021
- Artal Group 2020 Q3 filed Nov. 13, 2020
- Artal Group 2020 Q2 filed Aug. 14, 2020
- Artal Group 2020 Q1 filed May 14, 2020
- Artal Group 2019 Q4 filed Feb. 13, 2020
- Artal Group 2019 Q3 filed Nov. 14, 2019
- Artal Group 2019 Q2 filed Aug. 9, 2019
- Artal Group 2019 Q1 filed May 10, 2019
- Artal Group 2018 Q4 filed Feb. 11, 2019
- Artal Group 2018 Q3 filed Nov. 9, 2018
- Artal Group 2018 Q2 filed Aug. 10, 2018
- Artal Group 2018 Q1 filed May 10, 2018
- Artal Group 2017 Q4 filed Feb. 9, 2018
- Artal Group 2017 Q3 filed Nov. 8, 2017
- Artal Group 2017 Q2 filed Aug. 11, 2017
- Artal Group 2017 Q1 filed May 15, 2017